Target intelligence / Profile preview

MYT1L antisense RNA 1 (MYT1L-AS1)

Target
MYT1L-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

MYT1L antisense RNA 1 (MYT1L-AS1) is a long non-coding RNA transcribed antisense to the MYT1L gene. Like other antisense lncRNAs, MYT1L-AS1 is presumed to regulate the expression of the adjacent protein-coding MYT1L gene, potentially influencing processes such as neuronal differentiation and chromatin structure. Antisense lncRNAs can modulate gene expression at transcriptional and post-transcriptional levels, alter chromatin states, or influence splicing, but specific biological roles are not described in the current literature for MYT1L-AS1[3][6][8]. It has not been reported as a direct therapeutic target, nor are there established drugs or clinical biomarkers related to this RNA. If you intended to refer to the protein-encoding MYT1L gene, refer to "Myelin transcription factor 1 like (MYT1L)", which is an established transcription factor involved in neuronal differentiation[1][2][5][7][9]. In summary: MYT1L-AS1 is a validated lncRNA, not a therapeutic target, and its functional role is likely regulatory rather than as a drug target or receptor[3][6][8].

Other names
MYT1L-AS1MYT1L antisense RNA 1
02

Biological functions

Regulation of gene expression (cis or trans effects on the neighboring MYT1L gene)Chromatin modification and epigenetic regulation (generalizable; not confirmed for MYT1L-AS1 specifically, but is characteristic of antisense lncRNAs)
03

Disease associations

Other

Beyond the preview

Go deeper on MYT1L antisense RNA 1 (MYT1L-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYT1L antisense RNA 1 (MYT1L-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call